PMID- 22773410 OWN - NLM STAT- MEDLINE DCOM- 20130228 LR - 20171116 IS - 1439-0221 (Electronic) IS - 0032-0943 (Linking) VI - 78 IP - 12 DP - 2012 Aug TI - Deoxyschizandrin isolated from the fruits of Schisandra chinensis ameliorates Abeta(1)(-)(4)(2)-induced memory impairment in mice. PG - 1332-6 LID - 10.1055/s-0032-1315019 [doi] AB - In the present study, we examined the effects of deoxyschisandrin (DS) from Schisandra chinensis on the amyloid-beta(1)(-)(4)(2) (Abeta(1)(-)(4)(2))-induced memory impairment in mice and investigated the possible antioxidative mechanism. Mice were given an intracerebroventricular (i. c. v.) injection with the aggregated Abeta(1)(-)(4)(2) and then treated with DS (4, 12, and 36 mg/kg body weight) or donepezil (DPZ), a positive control drug (0.65 mg/kg), by intragastric infusion for 14 days. Non-cognitive disturbances and cognitive performance were evaluated by the locomotor activity, Y-maze, and water maze tests. Antioxidative enzyme activities including superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) and levels of malondialdehyde (MDA), glutathione (GSH), and oxidized glutathione (GSSG) within the cerebral cortex and hippocampus of mice were measured to investigate the mechanism. Our results showed that DS significantly improved Abeta(1)(-)(4)(2)-induced short-term and spatial memory impairments in the Y-maze and water maze tests. Furthermore, in the cerebral cortex and hippocampus of mice, the reduced activities of SOD and GSH-px, the GSH level, and the GSH/GSSG ratio were increased, and increased levels of MDA and GSSG were reduced following treatment with DS, although the improvement of GSH and the reduction of GSSG levels were not marked. These results suggest that DS is a potential cognitive enhancer in Alzheimer's disease through its antioxidative action. CI - Georg Thieme Verlag KG Stuttgart . New York. FAU - Hu, Di AU - Hu D AD - Department and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China. FAU - Li, Changxia AU - Li C FAU - Han, Na AU - Han N FAU - Miao, Lijing AU - Miao L FAU - Wang, Dong AU - Wang D FAU - Liu, Zhihui AU - Liu Z FAU - Wang, Hua AU - Wang H FAU - Yin, Jun AU - Yin J LA - eng PT - Journal Article DEP - 20120706 PL - Germany TA - Planta Med JT - Planta medica JID - 0066751 RN - 0 (Amyloid beta-Peptides) RN - 0 (Antioxidants) RN - 0 (Cyclooctanes) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Lignans) RN - 0 (Polycyclic Compounds) RN - 4Y8F71G49Q (Malondialdehyde) RN - 74XQL5DO3S (schizandrin A) RN - EC 1.11.1.9 (Glutathione Peroxidase) RN - EC 1.15.1.1 (Superoxide Dismutase) RN - GAN16C9B8O (Glutathione) SB - IM MH - Alzheimer Disease/drug therapy MH - Amyloid beta-Peptides MH - Animals MH - Antioxidants/*pharmacology MH - Cerebral Cortex/metabolism MH - Cyclooctanes/isolation & purification/*pharmacology MH - Drugs, Chinese Herbal/*pharmacology MH - Fruit/chemistry MH - Glutathione/metabolism MH - Glutathione Peroxidase/metabolism MH - Hippocampus/metabolism MH - Lignans/isolation & purification/*pharmacology MH - Male MH - Malondialdehyde/metabolism MH - Maze Learning/drug effects MH - Memory Disorders/chemically induced/*drug therapy/metabolism MH - Mice MH - Polycyclic Compounds/isolation & purification/*pharmacology MH - Schisandra/*chemistry MH - Superoxide Dismutase/metabolism EDAT- 2012/07/10 06:00 MHDA- 2013/03/01 06:00 CRDT- 2012/07/10 06:00 PHST- 2012/07/10 06:00 [entrez] PHST- 2012/07/10 06:00 [pubmed] PHST- 2013/03/01 06:00 [medline] AID - 10.1055/s-0032-1315019 [doi] PST - ppublish SO - Planta Med. 2012 Aug;78(12):1332-6. doi: 10.1055/s-0032-1315019. Epub 2012 Jul 6.